Influence of chitosan and its glutamate and hydrochloride salts on naproxen dissolution rate and permeation across Caco-2 cells

International Journal of Pharmaceutics

Volumn 271, Issue 1-2, 2004, Pages 257-267

  Maestrelli, F ^a   Zerrouk, N ^b   Chemtob, C ^b   Mura, P ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b FACULTÉ DES SCIENCES PHARMACEUTIQUES ET BIOLOGIQUES   (France)

Author keywords

Caco 2 cells; Chitosan; Chitosan salts; Dissolution; Enhancer effect; Naproxen

Indexed keywords

CHITOSAN; CHLORIDE; GLUTAMIC ACID; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; POLYMER; SODIUM CHLORIDE;

ARTICLE; CELL STRAIN CACO 2; DIFFERENTIAL SCANNING CALORIMETRY; DISSOLUTION; DRUG DOSAGE FORM; DRUG EFFICACY; DRUG MECHANISM; DRUG PENETRATION; DRUG SCREENING; DRUG TRANSPORT; ELECTRIC RESISTANCE; HUMAN; MONOLAYER CULTURE; PERMEABILITY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SIDE EFFECT; SOLID STATE; TIGHT JUNCTION; X RAY DIFFRACTION;

EID: 1142309796     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2003.11.024     Document Type: Article

References (22)

1. Açikgoz M., Kas H.S., Hasçelik Z., Milli U., Hincal A.A. Chitosan microspheres of diclophenac sodium, II: in vitro and in vivo evaluation. Pharmazie. 50:1995;275-277.
2. Amidon G.L., Lennernäs H., Shah V.P., Crison J.R. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 12:1995;413-420.
3. Artursson P. Cell culture as models for drug absorption across the intestinal mucosa. Crit. Rev. Ther. Drug Carrier Syst. 8:1991;105-130.
4. Artursson P., Lindinark T., Davis S.S., Illum L. Effect of chitosan on permeability of monolayer of intestinal epithelial cells (Caco-2). Pharm. Res. 11:1994;1358-1361.
5. Baldrick P. Pharmaceutical excipient development: the need for preclinical guidance. Regul. Tox. Pharmacol. 32:2000;210-218.
6. Borchard G., Lueßen H.L., de Boer A.G., Verhoef J.C., Lehr C., Junginger H.E. The potential of mucoadhesive polymer in enhancing intestinal peptide drug absorption. III: effect of chitosan-glutamate and carbomer on epithelial tight junction in vitro. J. Control. Rel. 39:1996;131-138.
7. Dodane V., Amin Khan M., Merwin J.R. Effect of chitosan on epithelial permeability and structure. Int. J. Pharm. 182:1999;21-32.
8. Genta I., Perugini P., Modena T., Pavanetto F., Castelli F., Muzzarelli R.A.A., Muzzarelli C., Conti B. Miconazole-loaded 6-oxychitin-chitosan microcapsules, Carbohydrate. Polymer. 52:2003;11-18.
9. Illum L. Chitosan and its use as a pharmaceutical excipient. Pharm. Res. 15:1998;1326-1331.
10. Karlsson J., Artursson P. A method for the determination of cellular permeability coefficients and aqueous boundary layer thickness in monolayers of intestinal epithelial (Caco-2) cells grown in permeable filter chambers. Int. J. Pharm. 71:1991;55-64.
11. Khan K.A. The concept of dissolution efficiency. J. Pharm. Pharm. 27:1975;48-49.
12. Kotzé A.F., de Leeuw B.J., Lueßen H.L., de Boer A.G., Verhoef J.C., Junginger H.E. Chitosans for enhanced delivery of therapeutics peptides across intestinal epithelia: in vitro evaluation in Caco-2 cell monolayers. Int. J. Pharm. 159:1997;243-253.
13. Lennernäs H., Palm K., Fagerholm U., Artusson P. Comparison between active and passive drug transport in human intestinal epithelial (Caco-2) cells in vitro and human jejunum in vivo. Int. J. Pharm. 127:1996;103-107.
14. Mura P., Zerrouk N., Mennini N., Maestrelli F., Chemtob C. Development and characterization of naproxen-chitosan solid system with improved drug dissolution properties. Eur. J. Pharm. Sci. 19:2003;67-75.
15. Niazi S.K., Alam S.M., Alirnad S.I. Dose dependent pharmacokinetics of naproxen in man. Biopharm. Drug Dispos. 17:1996;355-361.
16. Nogami H., Nagai T., Yotsuyanagi I. Dissolution phenomena of organic medicinals involving simultaneous plasse changes. Chem. Pharm. Bull. 17:1969;499-509.
17. Pade V., Stavchansky S. Estimation of the relative contribution of the transcellular and paracellular pathway to the transport of passively absorbed drugs in the Caco-2 cell culture model. Pharm. Res. 14:1997;1210-1215.
18. Pade V., Stavchansky S. Link between drug absorption solubility and permeability measurements in Caco-2 cells. J. Pharm. Sci. 87:1998;1604-1607.
19. Paul W., Sharma C.P. Chitosan, a drug carrier for the 21st century. S.T.P. Pharma Sci. 10:2000;5-22.
20. Portero A., Remuñan-Lopez C., Vila-Jato J.L. Effect of chitosan and chitosan glutamate enhancing the dissolution properties of the poorly water soluble drug nifedipine. Int. J. Pharm. 175:1998;75-84.
21. Schipper N.G.M., Varum K., Stenberg M.P., Ocklind G., Lennernäs H., Artursson P. Chitosan as absorption enhancers for poorly absorbable drugs: 3: influence of mucus on absorption enhancement. Eur. J. Pharm. Sci. 8:1999;335-343.
22. Zerrouk N., Mennini N., Maestrelli F., Chemtob C., Mura P. Comparison of the effect of chitosan and polyvynilpyrrolidone on dissolution properties and analgesic effect of naproxen. Eur. J. Pharm. Biopharm. 57:2004;93-99.